BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Week In Review: Big Week For IPOs


2/12/2007 1:48:53 PM

February 11, 2007 -- Friday’s 24-point drop put the Centient Biotech 200™ at 4050, a minor loss of 16 points or .40% for the week. Breadth was just slightly negative, which was right in line with a small decline. The IPO market continued its high level of activity, though it isn’t a market that could be called ebullient. Three biotechs made their debuts: Synta, 3SBio and Optimer. Among recent IPOs, BioMimetic gained 25%, but Achillion took a 54% hit. Tiny Valentis rose 46% as its reverse merger continues to make progress; Luminex gained 20% on positive earnings news; Accentia was an 18% winner.after an audit did not turn up more problems; Memory continued its stunning advance, rising another 17%; and XenoPort climbed 15% on its deal with GSK. More details...


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES